Nontuberculous Mycobacterial Infections Market to grow at a CAGR of 5.66% during 2024-2028
The Nontuberculous Mycobacterial Infections Market is expected to grow at a CAGR of 5.66% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 4.33 billion. In the realm of Nontuberculous Mycobacterial (NTM) Infections, precision medicine plays a pivotal role in advancing treatment modalities. By focusing on the unique genetic characteristics of various NTM strains, this approach facilitates the creation of targeted therapies. Genomic technologies have significantly enhanced our understanding of NTM strains' genetic makeup, enabling the identification of specific molecular targets for drug development. This knowledge empowers healthcare providers to develop personalized treatment plans, addressing the individual patient's genetic profile and the infecting NTM strain's specific traits, ultimately leading to improved patient outcomes.
Get more information on Nontuberculous Mycobacterial Infections Market by requesting a sample report
Technavio analysts predict that the Hospital pharmacies subsegment will lead the Distribution Channel segment during 2024 and 2028 Hospital pharmacies play a pivotal role in the distribution and management of pharmaceutical drugs utilized for the treatment of Nontuberculous Mycobacterial (NTM) infections within healthcare facilities. As key intermediaries, these pharmacies facilitate the procurement of essential medications, such as amikacin and ethambutol, from suppliers and pharmaceutical companies. Hospital pharmacies maintain an inventory of these drugs, which are readily accessible to healthcare professionals for the effective treatment of NTM infections. Inventory management systems enable pharmacies to monitor stock levels and ensure a consistent supply of NTM infection medications. Accurate documentation of patient data is imperative in the healthcare sector, and hospital pharmacies adhere to stringent protocols to maintain comprehensive records for efficient drug administration and patient care.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish growing prevalence of ntm globally
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
Nontuberculous Mycobacterial (NTM) Infections are caused by various strains of Mycobacterium, including the avium complex. These infections can affect different parts of the body such as the lungs, lymph nodes, bones, skin, and soft tissues. The diagnosis of NTM infections involves a combination of tests, including chest X-rays, CT scans, biopsy, and the Acid-fast bacilli (AFB) test. Symptoms include lung scarring, abscesses, and lung cavities. Complications include Lady Windermere syndrome, emphysema, asthma, cystic fibrosis, and lung conditions associated with immunosuppressive medications, cancer, and HIV. Causes of NTM infections include exposure to contaminated water, such as hot tubs, showers, and hot water heaters, as well as inhaling contaminated aerosols. Risk factors include vulnerability due to underlying lung conditions, advanced age, and weakened immune systems. The prognosis of NTM infections depends on the severity and location of the infection. Treatment typically involves antibiotics, but in some cases, surgery may be necessary. Prevention measures include avoiding exposure to contaminated water and maintaining good respiratory health. It is important to note that NTM infections are not the same as tuberculosis or leprosy, but they share some similarities in diagnosis and treatment methods.
According to Technavio, the global Nontuberculous Mycobacterial Infections (NTMIs) market is a segment of the expansive global pharmaceuticals industry, which encompasses entities involved in R&D or manufacturing of various pharmaceutical products, including generic, non-generic drugs, and veterinary drugs. The size of the global healthcare sector, which includes the pharmaceuticals market, is determined by Technavio based on the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors propelling the growth of the global pharmaceuticals market include the increasing elderly population, with the proportion of individuals above 60 years projected to surge significantly.
The Nontuberculous Mycobacterial Infections Market is experiencing significant growth, fueled by the growing prevalence of ntm globally. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
